ERAMET (ERA.PA) Stock Fundamental Analysis

EPA:ERA • FR0000131757

54.6 EUR
-3.7 (-6.35%)
Last: Mar 3, 2026, 05:29 PM
Fundamental Rating

2

Taking everything into account, ERA scores 2 out of 10 in our fundamental rating. ERA was compared to 39 industry peers in the Metals & Mining industry. Both the profitability and financial health of ERA have multiple concerns. ERA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year ERA has reported negative net income.
  • ERA had a negative operating cash flow in the past year.
  • Of the past 5 years ERA 4 years were profitable.
  • ERA had a positive operating cash flow in 4 of the past 5 years.
ERA.PA Yearly Net Income VS EBIT VS OCF VS FCFERA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

  • With a Return On Assets value of -1.58%, ERA is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
  • The Return On Equity of ERA (-9.29%) is worse than 74.36% of its industry peers.
  • ERA has a worse Return On Invested Capital (0.84%) than 69.23% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ERA is in line with the industry average of 8.60%.
  • The last Return On Invested Capital (0.84%) for ERA is well below the 3 year average (7.61%), which needs to be investigated, but indicates that ERA had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.58%
ROE -9.29%
ROIC 0.84%
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ERA.PA Yearly ROA, ROE, ROICERA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

  • ERA's Profit Margin has declined in the last couple of years.
  • ERA's Operating Margin of 1.91% is on the low side compared to the rest of the industry. ERA is outperformed by 66.67% of its industry peers.
  • In the last couple of years the Operating Margin of ERA has declined.
  • ERA has a Gross Margin of 68.15%. This is amongst the best in the industry. ERA outperforms 92.31% of its industry peers.
  • ERA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.91%
PM (TTM) N/A
GM 68.15%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
ERA.PA Yearly Profit, Operating, Gross MarginsERA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ERA is destroying value.
  • The number of shares outstanding for ERA has been increased compared to 1 year ago.
  • ERA has more shares outstanding than it did 5 years ago.
  • ERA has a better debt/assets ratio than last year.
ERA.PA Yearly Shares OutstandingERA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ERA.PA Yearly Total Debt VS Total AssetsERA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • ERA has an Altman-Z score of 1.10. This is a bad value and indicates that ERA is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of ERA (1.10) is worse than 71.79% of its industry peers.
  • ERA has a Debt/Equity ratio of 2.03. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of ERA (2.03) is worse than 87.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF N/A
Altman-Z 1.1
ROIC/WACC0.09
WACC9.7%
ERA.PA Yearly LT Debt VS Equity VS FCFERA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

  • ERA has a Current Ratio of 1.54. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
  • ERA's Current ratio of 1.54 is on the low side compared to the rest of the industry. ERA is outperformed by 66.67% of its industry peers.
  • ERA has a Quick Ratio of 1.06. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
  • ERA has a Quick ratio (1.06) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.06
ERA.PA Yearly Current Assets VS Current LiabilitesERA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2

3. Growth

3.1 Past

  • ERA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -219.63%.
  • Measured over the past years, ERA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -64.00% on average per year.
  • The Revenue has decreased by -6.91% in the past year.
  • Measured over the past years, ERA shows a decrease in Revenue. The Revenue has been decreasing by -4.39% on average per year.
EPS 1Y (TTM)-219.63%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%

3.2 Future

  • ERA is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -25.91% yearly.
  • The Revenue is expected to grow by 7.41% on average over the next years.
EPS Next Y-282.67%
EPS Next 2Y-47.83%
EPS Next 3Y-25.91%
EPS Next 5YN/A
Revenue Next Year4.29%
Revenue Next 2Y6.7%
Revenue Next 3Y7.41%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ERA.PA Yearly Revenue VS EstimatesERA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ERA.PA Yearly EPS VS EstimatesERA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ERA. In the last year negative earnings were reported.
  • Also next year ERA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ERA.PA Price Earnings VS Forward Price EarningsERA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

  • ERA's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.5
ERA.PA Per share dataERA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

  • ERA's earnings are expected to decrease with -25.91% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-47.83%
EPS Next 3Y-25.91%

0

5. Dividend

5.1 Amount

  • No dividends for ERA!.
Industry RankSector Rank
Dividend Yield 0%

ERAMET

EPA:ERA (3/3/2026, 5:29:52 PM)

54.6

-3.7 (-6.35%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-18
Earnings (Next)04-23
Inst Owners15.34%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap1.57B
Revenue(TTM)2.88B
Net Income(TTM)-97.00M
Analysts53.33
Price Target55.28 (1.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.51
Dividend Growth(5Y)N/A
DP-44.33%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.18%
PT rev (3m)6.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)9.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.29%
Revenue NY rev (3m)-0.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.54
P/FCF N/A
P/OCF N/A
P/B 1.5
P/tB 2.91
EV/EBITDA 15.5
EPS(TTM)-3.42
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)-25.76
FCFYN/A
OCF(TTM)-4.59
OCFYN/A
SpS100.31
BVpS36.3
TBVpS18.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.58%
ROE -9.29%
ROCE 1.16%
ROIC 0.84%
ROICexc 0.99%
ROICexgc 1.13%
OM 1.91%
PM (TTM) N/A
GM 68.15%
FCFM N/A
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ROICexc(3y)11.46%
ROICexc(5y)11.88%
ROICexgc(3y)13.48%
ROICexgc(5y)14.02%
ROCE(3y)10.76%
ROCE(5y)11.32%
ROICexgc growth 3Y-56.22%
ROICexgc growth 5Y-25.38%
ROICexc growth 3Y-55.33%
ROICexc growth 5Y-24.94%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
F-Score2
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF N/A
Debt/EBITDA 10.29
Cap/Depr 403.31%
Cap/Sales 21.11%
Interest Coverage 0.34
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.06
Altman-Z 1.1
F-Score2
WACC9.7%
ROIC/WACC0.09
Cap/Depr(3y)260.42%
Cap/Depr(5y)209.27%
Cap/Sales(3y)18.57%
Cap/Sales(5y)15.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-219.63%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
EPS Next Y-282.67%
EPS Next 2Y-47.83%
EPS Next 3Y-25.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%
Revenue Next Year4.29%
Revenue Next 2Y6.7%
Revenue Next 3Y7.41%
Revenue Next 5YN/A
EBIT growth 1Y-51.75%
EBIT growth 3Y-50.34%
EBIT growth 5Y-22.39%
EBIT Next Year-4.34%
EBIT Next 3Y30.7%
EBIT Next 5Y25.34%
FCF growth 1Y-850%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.46%
OCF growth 3YN/A
OCF growth 5YN/A

ERAMET / ERA.PA FAQ

What is the fundamental rating for ERA stock?

ChartMill assigns a fundamental rating of 2 / 10 to ERA.PA.


Can you provide the valuation status for ERAMET?

ChartMill assigns a valuation rating of 0 / 10 to ERAMET (ERA.PA). This can be considered as Overvalued.


Can you provide the profitability details for ERAMET?

ERAMET (ERA.PA) has a profitability rating of 3 / 10.


Can you provide the dividend sustainability for ERA stock?

The dividend rating of ERAMET (ERA.PA) is 0 / 10 and the dividend payout ratio is -44.33%.